First case of COVID-19 infused with hESC derived immunity- and matrix-regulatory cells

Jun Wu; Zhongjie Hu; Liu Wang; Yuanqing Tan; Wei Hou; Zhongwen Li; Tingting Gao; Jiaqi Fan; Baojie Guo; Huaping Dai; Wei Li; Jie Hao; Ronghua Jin; Baoyang Hu

doi:10.1111/cpr.12943

First case of COVID-19 infused with hESC derived immunity- and matrix-regulatory cells

Cell Prolif. 2020 Dec;53(12):e12943. doi: 10.1111/cpr.12943. Epub 2020 Oct 26.

Authors

Jun Wu^{1

2

3}, Zhongjie Hu⁴, Liu Wang^{1

2

3

5}, Yuanqing Tan^{1

2}, Wei Hou⁴, Zhongwen Li^{1

2

3}, Tingting Gao^{1

2

3

5}, Jiaqi Fan^{1

2}, Baojie Guo^{1

2

3

5}, Huaping Dai⁶, Wei Li^{1

2

3

5}, Jie Hao^{1

2

3}, Ronghua Jin³, Baoyang Hu^{1

2

3

5}

Affiliations

¹ National Stem Cell Resource Center, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
² Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, China.
³ State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
⁴ Beijing Youan Hospital, Capital Medical University, Beijing, China.
⁵ University of Chinese Academy of Sciences, Beijing, China.
⁶ National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.

No abstract available

Keywords: COVID-19; IMRCs; case report; cell therapy; hESC.

Publication types

Case Reports
Letter

MeSH terms

Acute Lung Injury / diagnostic imaging
Acute Lung Injury / immunology
Acute Lung Injury / therapy*
Adult
COVID-19 / complications
COVID-19 / pathology*
COVID-19 / virology
Cell Differentiation
Cytokines / blood
Human Embryonic Stem Cells / cytology*
Human Embryonic Stem Cells / metabolism
Humans
Male
SARS-CoV-2 / isolation & purification
T-Lymphocytes, Regulatory / cytology
T-Lymphocytes, Regulatory / metabolism
T-Lymphocytes, Regulatory / transplantation*
Tomography, X-Ray Computed

Substances

Cytokines

Publication types

MeSH terms

Substances

Grants and funding